Overview
Safety and Efficacy of Chronic Hypnotic Use 2
Status:
Recruiting
Recruiting
Trial end date:
2023-12-01
2023-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood effects, zolpidem.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Henry Ford Health SystemTreatments:
Eszopiclone
Hypnotics and Sedatives
Zolpidem
Criteria
Inclusion Criteria:- DSM-5 diagnosis of insomnia
Exclusion Criteria:
- acute or unstable medical disease,
- current or past history of psychiatric disease, alcoholism or drug abuse, and other
primary sleep disorders